Ultra-Expensive Drugs And Medicare Part D: Spending And Beneficiary Use Up Sharply.
2021
The proliferation of “ultra-expensive” drugs has sparked debate on their sustainability and affordability. Medicare Part D’s share of annual spending on these drugs increased by 1,170 percent betwe...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
0
Citations
NaN
KQI